imPURE | Injection Moulding Repurposing for Medical Supplies enabled by Additive Manufacturing

Summary
The modern world is fast-evolving, interconnected and highly mobile, thus posing a significant challenge in harmonizing risk mitigation measures against emerging biological hazards. For many years the risk of emerging infectious diseases with pandemic potential was declared a major threat to global health security and addressed by many stakeholders around the world. The delay in imposing risk mitigation measures is crucial and can make the difference between a local outbreak with few cases to a pandemic with countless sick and deceased citizens, as severely demonstrated by the recent outbreak of Coronavirus disease 2019 (COVID-19). It is of paramount importance that appropriate and proportionate measures to each phase of the pandemic (e.g. from situations with no reported cases, sporadic, local clusters of cases, to widespread sustained transmission) are immediately implemented to interrupt human-to-human transmission chains, prevent further spread and reduce the intensity of COVID-19 outbreak. Immediate activation of national emergency response mechanisms and pandemic preparedness plans to ensure containment and mitigation of COVID-19 with non-pharmaceutical public health measures is critical for delaying transmission or decreasing the peak of the outbreak, in order to allow healthcare systems to prepare and cope with an increased influx of patients. However, shortages and other gaps in the global medical supply chain represent a mismatch of supply and demand when supply is low and/or demand is high for particular items. With healthcare workers and other first responders feeling the impact of supply chains disrupted by unprecedented challenges, many large and small businesses from outside the traditional healthcare procurement system are reconfiguring to mass produce critical medical consumables. In order to address supply shortages, particularly in medical supplies and protective equipment, some countries have employed less traditional instruments.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101016262
Start date: 01-12-2020
End date: 31-05-2022
Total budget - Public funding: 7 261 637,00 Euro - 5 783 800,00 Euro
Cordis data

Original description

The modern world is fast-evolving, interconnected and highly mobile, thus posing a significant challenge in harmonizing risk mitigation measures against emerging biological hazards. For many years the risk of emerging infectious diseases with pandemic potential was declared a major threat to global health security and addressed by many stakeholders around the world. The delay in imposing risk mitigation measures is crucial and can make the difference between a local outbreak with few cases to a pandemic with countless sick and deceased citizens, as severely demonstrated by the recent outbreak of Coronavirus disease 2019 (COVID-19). It is of paramount importance that appropriate and proportionate measures to each phase of the pandemic (e.g. from situations with no reported cases, sporadic, local clusters of cases, to widespread sustained transmission) are immediately implemented to interrupt human-to-human transmission chains, prevent further spread and reduce the intensity of COVID-19 outbreak. Immediate activation of national emergency response mechanisms and pandemic preparedness plans to ensure containment and mitigation of COVID-19 with non-pharmaceutical public health measures is critical for delaying transmission or decreasing the peak of the outbreak, in order to allow healthcare systems to prepare and cope with an increased influx of patients. However, shortages and other gaps in the global medical supply chain represent a mismatch of supply and demand when supply is low and/or demand is high for particular items. With healthcare workers and other first responders feeling the impact of supply chains disrupted by unprecedented challenges, many large and small businesses from outside the traditional healthcare procurement system are reconfiguring to mass produce critical medical consumables. In order to address supply shortages, particularly in medical supplies and protective equipment, some countries have employed less traditional instruments.

Status

CLOSED

Call topic

SC1-PHE-CORONAVIRUS-2020-2A

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.5. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing
H2020-EU.2.1.5.0. Cross-cutting call topics
H2020-SC1-PHE-CORONAVIRUS-2020-2-NMBP
SC1-PHE-CORONAVIRUS-2020-2A Repurposing of manufacturing for vital medical supplies and equipment.